All terms in EFO
| Label | Id | Description |
|---|---|---|
| positive regulation of glucagon secretion | GO_0070094 | [Any process that activates or increases the frequency, rate or extent of the regulated release of glucagon.] |
| dermatological toxicity | EFO_0011048 | [Toxicity that causes injury to the skin and subcutaneous tissue or damages its function. This can include severe dermatitis, Stevens-Johnson syndrome, urticaria. ] |
| central nervous system toxicity | EFO_0011047 | [Toxicity that causes injury to the central nervous system or damages its function. This can include stroke, multiple sclerosis, encephalopathy, dementia, Alzheimer's disease, dyskinesia, tremor, convulsions and Parkinson's disease.] |
| neurotoxicity | EFO_0011057 | [Toxicity that causes injury to the central or peripheral nervous system or damages its function. This can include stroke, multiple sclerosis, encephalopathy, dementia, Alzheimer's disease, amnesia, dyskinesia, Parkinson's disease, tremor, convulsions and Guillain Barre syndrome. ] |
| carcinogenicity | EFO_0011046 | [Toxicity that causes or increases the incidence of malignant neoplasia (cancer). This can include carcinoma, sarcoma, lymphoma, leukemia.] |
| fetal weight | EFO_0011045 | [The mass or quantity of heaviness of an fetus in utero. It is expressed by units of pounds or kilograms.] |
| body weight | EFO_0004338 | [The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.] |
| BMI-adjusted neck circumference | EFO_0011044 | [A circumferential measurement of the neck that has been adjusted for subjects' body mass index.] |
| neck circumference | EFO_0011043 | [A circumferential measurement of the neck.] |
| response to BCG intravesical immunotherapy | EFO_0011041 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of the intravesical administration of Mycobacterium bovis BCG solution. Live attenuated BCG is used as a therapeutic agent for non-muscle invasive bladder cancer.] |
| Mohr-Tranebjaerg syndrome | Orphanet_52368 | [Mohr-Tranebjaerg syndrome (MTS) is an X-linked recessive neurodegenerative syndrome characterized by clinical manifestations commencing with early childhood onset hearing loss, followed by adolescent onset progressive dystonia or ataxia, visual impairment from early adulthood onwards and dementia from the 4th decade onwards.] |
| silicon | CHEBI_27573 | [A carbon group element that has formula Si., A carbon group element atom that has formula Si.] |
| carbohydrate metabolic process | GO_0005975 | [ The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule. ] |
| (15Z)-12-oxophyto-10,15-dienoic acid | CHEBI_15560 | [Expressed in keratinocytes by human FABP5 Gene (FABP Family), highly conserved 135-aa 15-kDa cytoplasmic Fatty Acid Binding Protein 5 binds long-chain fatty acids with high specificity, and other hydrophobic ligands. Likely involved in fatty acid uptake, transport, or metabolism and in keratinocyte differentiation, FABP5 has highest affinity for C18 chain lengths and decreasing affinity for decreasing chain lengths or chains with double bonds. (NCI), An omega-3 fatty acid that has formula C18H28O3.] |
| myeloperoxidase (MPO)-DNA complex measurement | EFO_0011039 | [Quantification of myeloperoxidase (MPO)-DNA complex levels in a biological specimen. Plasma MPO-DNA complex levels typically measured by immunofluorescence or ELISA are used to detect neutrophil extracellular trap (NETs) formation.] |
| anti-human herpes virus 7 antibody measurement | EFO_0011038 | [Quantification of the amount of antibody to human herpes virus 7 in a sample.] |
| anti-human herpes virus 6 antibody measurement | EFO_0011037 | [Quantification of the amount of antibody to human herpes virus 6 in a sample.] |
| matrix metalloproteinase–degraded type I collagen measurement | EFO_0011036 | [Quantification of matrix metalloproteinase-degraded type I collagen (also known as metabolite of type I collagen) in a sample.] |
| TP segment duration | EFO_0011035 | [Electrocardiography measurement of the duration from the end of the T wave to the start of the P wave.] |
| T wave duration | EFO_0011034 | [Electrocardiography measurement of the duration from the start of the T wave to the end of the T wave.] |